Back to search results

Personalizing Treatment for Anxiety and Alcohol Use

This study is exploring how to best personalize treatment for people experiencing anxiety or trauma-related symptoms and problems with alcohol use. Researchers are comparing three approaches: a personalized cognitive behavioral therapy (CBT) skills intervention, a standard CBT skills intervention, and supportive counseling. The goal is to see which approach is most effective at reducing alcohol-related risk, problem drinking, and anxiety symptoms over approximately 15 weeks. You may be able to join if you are between 18 and 65, have anxiety or trauma-related symptoms and alcohol use problems, and are interested in telehealth counseling. The study is currently unclear on its recruitment status and plans to enroll 81 participants.

Study design
This interventional study will enroll 81 participants. It compares three different behavioral interventions.
What's involved
You would receive 11 sessions of either cognitive behavioral therapy skills or supportive counseling. Your progress will be tracked over approximately 15 weeks.
Compensation
Not stated in the trial record.
Follow-up
Your progress will be measured at various points up to approximately Week 15.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05821634

Personalizing Treatment Delivery

Enrolling by Invitation
NAAges 18–65InterventionalTreatment
Rutgers, The State University of New Jersey
~81 participants
Updated 2026-07-30 on ClinicalTrials.gov
What's tested:Personalized intervention condition: Cognitive behavioral therapy skillsTherapeutic control condition: Cognitive behavioral therapy skillsTracking control condition: Supportive counseling

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in alcohol related risk
Measured over Week 3, Week 15 (approximate)
+3 more outcomes measured

Conditions

Anxiety Disorders and Symptoms
PTSD and Trauma-related Symptoms
Alcohol; Use, Problem; Alcohol Use Disorder

Explore related trials

Alcohol use disorderAnxiety DisorderPost-Traumatic Stress Disorder

Where it's being run

1 sites across 1 states
New Jersey1

Study leadership

  • Marilyn Piccirillo, PhD · PRINCIPAL_INVESTIGATOR · Rutgers Robert Wood Johnson Medical School

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Access to a smart phone
Between 18 and 65 years
Clinically significant anxiety or trauma-related symptoms
Alcohol use problems
Interest in telehealth counseling
Anticipated New Jersey or New York residence for the duration of the study

Exclusion

Currently receiving individual counseling or counseling at a higher level of care
Psychiatric medication that is not currently at a stable dose (or is not anticipated to remain at a stable dose for the duration of the study)
Demonstrated indicators of more intensive or acute care
Temporary residence within the state of New Jersey or New York or out-of-state residence from the state of New Jersey or New York

What this trial measures

  • Change in alcohol related riskWeek 3, Week 15 (approximate)

    The Alcohol Use Disorder Identification Test (AUDIT) self-report measure (or similar) will be used to assess changes in alcohol related risk.

  • Change in risk drinking levelsWeek 3, Week 4, Week 5, Week 6, Week 7, Week 8, Week 9, Week 10, Week 11, Week 12, Week 13, Week 14, Week 15 (approximate)

    The Daily Drinking Questionnaire (DDQ) self-report measure (or similar) will be used to measure changes in alcohol consumption/risk drinking levels.

  • Change in anxiety or anxiety-related symptom severityWeek 3, Week 4, Week 5, Week 6, Week 7, Week 8, Week 9, Week 10, Week 11, Week 12, Week 13, Week 14, Week 15 (approximate)

    The Overall Anxiety Severity and Impairment Scale (OASIS) self-report measure (or similar) will be used to assess changes in anxiety and anxiety-related symptom severity.

  • Change in psychiatric diagnosesWeek 3, Week 15 (approximate)

    A diagnostic interview will be used to assess change in psychiatric diagnoses at the beginning and end of participation.